Annalisa Saltari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Annalisa Saltari has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Dzung
Department of Dermatology University Hospital Zurich, University of Zurich Zurich Switzerland
153 shared publications - Reinhard Dummer
Department of Dermatology, University Hospital Zürich, University of Zurich, 8091 Zurich, Switzerland
153 shared publications - Ossia M. Eichhoff
Department of Dermatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland
152 shared publications - Patrick Turko
Department of Dermatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland
152 shared publications - Phil Fang Cheng
Department of Dermatology, University of Zurich Hospital and Faculty of Medicine, University of Zurich, Zurich, Switzerland
152 shared publications - Mitchell Paul Levesque
Department of Dermatology, University of Zurich, University Hospital Zurich, Zurich, Switzerland
137 shared publications
Latest Publications
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable ST2 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Table ST2: Summary of the clinical data corresponding to the primary cell cultures used in this publication
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Data from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Tumor Profiler Consortium author list
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Data from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Tumor Profiler Consortium author list
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table ST6 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Table ST6: Differential expressed lipids and their FDRs in sensitive vs resistant cells (negative values are upregulated in sensitive cells).
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable ST6 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Table ST6: Differential expressed lipids and their FDRs in sensitive vs resistant cells (negative values are upregulated in sensitive cells).
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Suppl. Figure S8 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure S8 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Suppl Figure S4 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S4: Neocuproine is a copper-dependent ROS inducer
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl Figure S4 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S4: Neocuproine is a copper-dependent ROS inducer
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Suppl. Figure S1 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S1: Evaluation of HST screening.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure S1 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S1: Evaluation of HST screening.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Suppl. Figure S15 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S15: Tumor response curves in mice for ionophoric copper-chelators in combination with binimetinib.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure S15 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S15: Tumor response curves in mice for ionophoric copper-chelators in combination with binimetinib.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Suppl. Figure S3 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S3: Correlation between MEKi responsiveness and sensitivity to nNeocuproine
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure S3 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S3: Correlation between MEKi responsiveness and sensitivity to nNeocuproine
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Suppl. Figure S6 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S6: Correlation analysis between MEKi and ROS.
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSuppl. Figure S6 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
S6: Correlation analysis between MEKi and ROS.
- Open Access
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Table ST4 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Table ST4: Table of the 15 most informative proteins upregulated in MEK inhibitor-sensitive cell culture (ranked by log2 fold-change).
- 24 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable ST4 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma
Table ST4: Table of the 15 most informative proteins upregulated in MEK inhibitor-sensitive cell culture (ranked by log2 fold-change).